| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA1563670
Max Phase: Preclinical
Molecular Formula: C30H28N2O4
Molecular Weight: 480.56
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COc1ccc(OCc2cc(C3Nc4ccccc4C(=O)N3Cc3ccccc3)ccc2OC)cc1
Standard InChI: InChI=1S/C30H28N2O4/c1-34-24-13-15-25(16-14-24)36-20-23-18-22(12-17-28(23)35-2)29-31-27-11-7-6-10-26(27)30(33)32(29)19-21-8-4-3-5-9-21/h3-18,29,31H,19-20H2,1-2H3
Standard InChI Key: GNMRMJHARVGSIT-UHFFFAOYSA-N
Associated Targets(Human)
TSHR Tclin Thyroid stimulating hormone receptor (29986 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 480.56 | Molecular Weight (Monoisotopic): 480.2049 | AlogP: 6.05 | #Rotatable Bonds: 8 |
| Polar Surface Area: 60.03 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 12.43 | CX Basic pKa: | CX LogP: 6.25 | CX LogD: 6.25 |
| Aromatic Rings: 4 | Heavy Atoms: 36 | QED Weighted: 0.33 | Np Likeness Score: -0.72 |
References
| 1. PubChem BioAssay data set, |
| 2. Englund EE, Neumann S, Eliseeva E, McCoy JG, Titus S, Zheng W, Southall N, Shin P, Leister W, Thomas CJ, Inglese J, Austin CP, Gershengorn MC, Huang W.. (2011) The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor Agonists., 2 (10): [PMID:22408719] [10.1039/c1md00145k] |
Source
Source(2):